Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: john b who wrote (646)	4/8/1998 6:43:00 PM
From: Mr. Punisher	Respond to of 998

Well, I am one of those guys who, believing the risk to be too high with the underlying, went for the out of the money calls to participate in the upside. I totally concur with everyone who cites the provigil part of the pipeline as one with tremendous potential. If it could be another ritalin, look out. I think the market is saying, great, the narcoleptic market is not that large. But if it is used as a ritalin-type stimulant, think about the market potential. I am still shying away from the underlying and looking for the options again, but until the timing can be cleared up, I am on the sidelines. Is May 11 still intact? Do we have a confirmation on that fact? I think it is a critical question for the company/IR to answer, but I don't think they even know. I still believe that the panel would have to have done the dirty work. Good luck guys and cheers to informed posters like yourselves.